Ophthalmology Doctors in Venice, CA Accepting Medicare

2 Ophthalmology doctors found. Showing 1 - 2

Amy B Halikman, M.D. Ophthalmology Medicare: Not Enrolled in Medicare Practice Location: 2554 Lincoln Blvd, Apartment # 418, Venice, CA 90291 Phone: 310-927-4834

Dr. Scott Albert Dunn, M.D., F.A.C.S. Ophthalmology Medicare: Not Enrolled in Medicare Practice Location: 630 Milwood Ave, Venice, CA 90291 Phone: 310-577-3037

News Archive

Study shows unexpected mechanism for lipid acquisition by breast cancer cells

High-fat diets and obesity have been shown to increase the risk of breast cancer and worsen outcomes and prognosis of breast cancer patients. A team of researchers from Dartmouth and Dartmouth-Hitchcock Norris Cotton Cancer Center led by William Kinlaw III, MD, sought to understand how fat from the diet might influence breast cancer cells.

ZOLL Medical revenues for third-quarter fiscal 2010 up 17% to $111.3 million

ZOLL Medical Corporation, a manufacturer of resuscitation devices and software solutions, today announced that revenues for the third quarter of fiscal 2010 increased 17% to $111.3 million, compared to revenues in the third quarter of last year of $95.1 million. The third quarter 2010 results included approximately $5.0 million of revenue from the Temperature Management business, compared to $1.9 million of revenue in the third quarter of last year.

Johns Hopkins researchers identify barriers to young men's sexual and reproductive health

Johns Hopkins researchers who conducted a dozen focus groups with 70 straight and gay/bisexual Hispanic and African-American males ages 15 to 24 report that gaining a better understanding of the context in which young men grow up will allow health care providers to improve this population's use of sexual and reproductive health care.

Medinol introduces NIRxcell CoCr Stent System to coronary marketplace

During the recent 2015 Transcatheter Cardiovascular Therapeutics Meeting held in San Francisco, CA, Medinol Ltd. continued to introduce novel stent solutions to the coronary marketplace. During a satellite symposium, "The BioNIR eDES: The Role of Uniformity in Stent Design to Minimize Restenosis", a renowned physician panel discussed the key attributes of the currently available Medinol NIRxcell CoCr Coronary Stent System and the Medinol eDES Coronary Stent System (in trials, not FDA/CE Mark approved).

Kidney treatments may be improved with new understanding of cell death mechanism

Finding how two proteins conspire to get kidney cells to self-destruct when oxygen supplies are low may one day improve dismal mortality rates for ischemic renal failure, researchers say.

Read more Medical News

› Verified 8 days ago